Dupont Jakob bought PYXS
June 30, 2026 · Form 4 insider transaction
Dupont Jakob bought 35,000 shares of Pyxis Oncology, Inc. at $1.60 per share, a transaction worth $56.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
35,000
Price
$1.60
Total value
$56.0K
InsiderDupont Jakob
RoleDirector
CompanyPyxis Oncology, Inc. (PYXS)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after73,741
OwnershipDirect
10b5-1 planNo
AmendedNo